Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Allergan, Inc.    AGN

SummaryQuotesNewsCalendarCompanyFinancials 
News SummaryMost relevantAll newsSector newsTweets 
The feature you requested does not exist. However, we suggest the following feature:

Allergan : Dr. Justin Harper Selected for Allergan's Facial Aesthetics National Advisory Board

share with twitter share with LinkedIn share with facebook
share via e-mail
0
03/28/2017 | 09:01am CEST

Columbus, Ohio (PRWEB) March 28, 2017

Columbus OH. Dr. Justin Harper, Founder of Juvly Aesthetics in Ohio and New York City was selected as one of few medical professionals in the country to sit on the 2017 National Advisory Board for Allergan's Facial Aesthetics National Advisory Board.
 
As Founder of Juvly Aesthetics, in just 2 years Dr. Harper helped propel the clinic from a small start-up to number 78 in the country based on sales volume of Allergan cosmetic products, while earning 5 star ratings from Juvly clients. Juvly's motto is fair prices and fantastic results, and all prices are posted online at http://www.juvly.com/pricing.
 
"The invitation by Allergan to serve on this Advisory Board is not only an honor but also a great example of Allergan's commitment to research and development," he said. "I am hopeful that our Board's contributions will help facial aesthetics clients all over the country receive the most appropriate and cutting edge treatments available. The Advisory Board is meeting in April 2017 in Chicago.
 
About Juvly Aesthetics
Founded by Dr. Justin Harper in 2014, Juvly Aesthetics has grown to one of the largest and most highly acclaimed aesthetic practices in the country. Juvly has offices in Columbus, OH, New York, NY, Cincinnati, OH and Polaris, OH. The clinic specializes in non-surgical aesthetic procedures including Allergan's portfolio of injectable products. In addition, Juvly offers anti-aging laser procedures, non-surgical fat reduction with Coolsculpting and Cellfina cellulite reduction treatments.
 
About Allergan 
Allergan is the global multi-specialty health care corporation that produces cosmetic products such as Botox®, Juvederm®, Juvederm Voluma®, Kybella®, Juvederm Volbella®, Latisse® and SkinMedica®. Allergan also recently acquired Zeltiq, the makers of Coolsculpting®.
 
Contact Information
Juvly Aesthetics
40 West Gay Street
Columbus, OH 43215
(614) 686-3627
http://www.juvly.com
info(at)juvly(dot)com

Read the full story at http://www.prweb.com/releases/2017/02/prweb14091670.htm

(c) 2017 PRWEB.COM Newswire, source Press Releases

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ALLERGAN, INC.
09:01a ALLERGAN : Dr. Justin Harper Selected for Allergan's Facial Aesthetics National ..
03/27 ALLERGAN : and Paratek Show Positive Results For Acne Treatment
03/27 PARATEK PHARMACEUTICALS, INC. (NASDA : PRTK) Files An 8-K Regulation FD Disclosu..
03/27 ALLERGAN : What Are Inversion Deals?
03/24 GLOBAL GLAUCOMA THERAPEUTICS MARKET : Allergan, Merck, Novartis, Pfizer, Santen..
03/24 GLOBAL GASTROINTESTINAL DRUGS MARKET : Abbott Laboratories, Allergan, AstraZenec..
03/22 Global Inhalation & Nasal Spray Generic Drugs Market- Teva, Allergan PLC, Cip..
03/22 ALLERGAN : Announces Availability of RESTASIS MULTIDOSE™ (Cyclosporine Oph..
03/20 ALLERGAN : JUVÉDERM VOLLURE™ XC Approved by U.S. FDA for Correction of Fac..
03/17 ALLERGAN : Prevent Blindness and Allergan Work Together Through See America to P..
More news
Sector news : Pharmaceuticals - NEC
08:48aDJDuPont, Dow Get EU Approval for Merger -- WSJ
03/27DJALEXION PHARMACEUTICALS : Names New CEO Following Internal Sales-Practice Probe
03/27DJEU Clears Dow-DuPont Deal With Conditions -- 2nd Update
03/27DJEU Clears Dow-DuPont Deal With Conditions -- Update
03/27 Chinese drug approval boosts AstraZeneca's lung cancer hopes
More sector news : Pharmaceuticals - NEC
News from SeekingAlpha
2015 MANNKIND : A Head Pain Gain Or A Pocket-Book Drain?
2015 Tracking Dan Loeb's Third Point Portfolio - Q1 2015 Update
2015 Tracking Ole Andreas Halvorsen's Viking Global Portfolio - Q1 2015 Update
2015 Time Warner Is A Buy - Cramer's Lightning Round (5/21/15)
2015 Tracking John Paulson's Paulson & Company Portfolio - Q1 2015 Update
Advertisement
Income Statement Evolution
More Financials
Managers
NameTitle
Ambrose Robert Douglas Bailey Chief Executive Officer
Maria Teresa Hilado Chief Financial Officer
Scott M. Whitcup Chief Scientific Officer & Executive VP-Research
Raymond H. Diradoorian Executive VP-Global Technical Operations
Joann Bradley Investor Relations Contact
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ALLERGAN, INC.13.00%0
JOHNSON & JOHNSON8.91%341 030
ROCHE HOLDING LTD.8.73%220 248
PFIZER INC.5.23%203 546
NOVARTIS AG-0.47%195 735
MERCK & CO., INC.7.34%173 493
More Results